Seed Stage Judges
Aydin Senkut, Felicis Ventures
Aydin Senkut is the founder and managing director of Felicis Ventures. He has been named one of the top 25 tech angels by Businessweek recently. Aydin's been an angel investor in promising start-ups since 2006. His portfolio encompasses over 50 companies including Aardvark (acquired by Google), Brightroll, Disqus, Erply, Imageshack, Inkling, Justin.tv, Meraki, Mint (acquired by Intuit), Mochi Media (acquired by Shanda Games), Outright, Posterous, Powerset (acquired by Microsoft), Plusmo (acquired by AT&T), Practice Fusion, RichRelevance, Sendori (acquired by IAC), Tapulous (acquired by Disney), and Yume Networks.
Jeff Tangney, Doximity
Jeff is the founder and CEO of Doximity. He previously was the co-founder, president and chief operating officer of Epocrates, a recent IPO and the most successful professional medical mobile app of all time. He was the Ernst & Young Entrepreneur of the Year for Northern California in 2006 and is a graduate of the Stanford Graduate School of Business.
Chaim Indig, Phreesia
Since co-founding Phreesia in 2005, president and CEO Chaim Indig has lead a team in establishing Phreesia as the premier patient check-in solution. Phreesia has expedited check-in for thousands of doctors' offices and hospitals nationwide, revolutionized the patient check-in process, partnered with some of the most respected healthcare companies in the industry and grown into a team of over 100 highly enthusiastic employees. Prior to founding Phreesia, Chaim led the successful introduction of Spotfire, the leader in high-end analytics software, into the pharmaceutical sales and marketing space in the United States and established them as a recognized name in Canada.
Robert Fassett, MD, Oracle
As Oracle's chief medical informatics officer, Rob is responsible for channeling Oracle's healthcare R&D investments into the development of new products and services that will help providers and life sciences companies transform the practice of medicine. Most recently Rob created Oracle's enterprise healthcare data warehousing and analytics suite of products that have been acquired by nearly 100 hospitals. Before joining Oracle, Rob founded a speech recognition software company that was acquired by Oracle. Rob was also a co-founder of a gene therapy startup and has served as a consultant and scientific advisor to several biotech companies. Rob is a primary care physician and graduate of UCLA School of Medicine. Rob received his undergraduate degree in molecular biology at UCSD.
Dr. Enoch Choi, MD, Palo Alto Medical Foundation
Dr. Enoch Choi, MD is a full-time Family Medicine physician practicing urgent care as a partner at Palo Alto Medical Foundation providing hands-on healing as well as virtual care via a personal health record. As medical director of Jordan International Aid, he provides disaster relief with dozens of trips to Japan and Haiti sending hundreds of providers. He speaks nationally about physician social media, mHealth, EHR & disaster medical relief. He helped take Medicalogic public and provided EHR consulting to Sutter, Epic & Misys. Enoch chairs the board of Yew Chung International School and serves on the boards of Palo Alto Community Fund and Pelesend. He volunteers his time as a Standing Member of an AHRQ HSR Study Section, and as a provider at the free Community Pregnancy Center of Mountain View. He has advised Health2.0, Medicine2.0, IDEO, IFTF, BVP, MDV, SToRM, Maveron and other firms.
Series A Judges
Rebecca Lynn, Morgenthaler Ventures
Rebecca is a partner at Morgenthaler Ventures where she focuses on early-stage investments in health IT, mobile, Internet services and financial services. She serves on the boards of Practice Fusion, Lending Club, Socrata, and Pageonce. Rebecca began her career at Procter and Gamble and focused on international new product market entry. She then joined NextCard where she served as the vice president of marketing, managing one of the top-five largest online marketing efforts at the time. Rebecca passed the California State Bar and has a focus on intellectual property litigation and corporate law. Rebecca is an inventor on several issued patents. She was also published in the Berkeley Law and Technology Journal.
Brian Ascher, Venrock
Brian Ascher joined Venrock in 1998 as a Kauffman Fellow and is currently a partner based in Palo Alto. Brian focuses on Healthcare IT and general Internet investments. Brian's current Healthcare IT investments include Vocera and Awarepoint, and he was a past director of RelayHealth up until its acquisition by McKesson. Prior to Venrock, Brian was a senior product manager at Intuit responsible for Quicken and Quicken.com, and earlier in his career was a strategy consultant at the Monitor Group. Brian has been named to the Forbes Midas List, which ranks the top venture capitalists, multiple times including the current edition. Brian received his B.A. from Princeton and his M.B.A. from Stanford.
Tim Chang, Partner, Mayfield Fund
Tim is a managing director at Mayfield Fund. He was named on the 2011 Forbes Midas List of Top 100 Dealmakers, was featured by The Deal as one of five emerging VCs to watch and by the AlwaysON Hollywood IT List recognizing technology leaders in the digital entertainment industry. Previously at Norwest Venture Partners, Tim invested in the mobile, gaming and digital media sectors and established their investment practice in China and Asia Pacific. Some of Tim's notable U.S.investments include ngmoco (acquired by DeNA), Playdom (acquired by Disney), and Iridigm Display Corporation (acquired by Qualcomm). Some of Tim's notable China investments include AdChina, Lashou, and PCH International.
Alex de Winter
Alex de Winter is a partner in Mohr Davidow's life science practice, where he evaluates investments in personalized medicine and healthcare. Prior to Mohr Davidow, he was an early employee and scientist at 454 Life Sciences and later at Pacific Biosciences. Alex has a Ph.D. in Chemistry from Stanford, and an MBA from UC Berkeley.
Martin Felsenthal, HLM Venture Partners
Marty is a partner of HLM Venture Partners. He has been involved in the founding of Vantage Oncology, today one of the largest operators of radiation treatment centers in the country, and Vericare, the largest provider of behavioral health care services to nursing home patients in the country. He has also invested in and served on the boards of one of the largest independent home care companies in the country, one of the largest independent dialysis center companies in the country, and Payerpath, a leading revenue cycle management company that was acquired by Misys in 2006. At HLM Venture Partners, some of Marty's investments include Teladoc (a leading telemedicine services company), Aperio (the global leader in digital pathology), and CombiMatrix Diagnostics (a molecular genetics lab). He received a BA from Princeton University and an MBA from the Stanford University Graduate School of Business.